Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Loomis
J Herman

Showing results (681-690 of 709) with videos related to

Pageof 71
Sort By:
Nature Immunology|June 22, 2026
Fate induction through asymmetric T cell division is modulated by chimeric antigen receptor costimulatory domainsCaitlin S Frazee, Sisi Chen, Corbett T Berry, et al.
The American Journal of Sports Medicine|October 17, 2025
Risk Profile for Cyclops Syndrome Necessitating Reoperation After Anterior Cruciate Ligament ReconstructionTing Cong, Sahil Dadoo, Jumpei Inoue, et al.
Lung Cancer (Amsterdam, Netherlands)|May 19, 2024
Single organ metastatic sites in non-small cell lung cancer: Patient characteristics, treatment patterns and outcomes from a large retrospective Canadian cohortY Li, M Wong, L Zhan, et al.
Bioorganic & Medicinal Chemistry Letters|September 18, 2012
Optimization of an ether series of mGlu5 positive allosteric modulators: molecular determinants of MPEP-site interaction crossoverJason T Manka, Paige N Vinson, Karen J Gregory, et al.
Molecular Pharmacology|October 7, 2010
Discovery of novel allosteric modulators of metabotropic glutamate receptor subtype 5 reveals chemical and functional diversity and in vivo activity in rat behavioral models of anxiolytic and antipsychotic activityAlice L Rodriguez, Mark D Grier, Carrie K Jones, et al.
Frontiers in Plant Science|February 17, 2018
Latitudinal Patterns in European Seagrass Carbon Reserves: Influence of Seasonal Fluctuations versus Short-Term Stress and Disturbance EventsLaura M Soissons, Eeke P Haanstra, Marieke M van Katwijk, et al.
Journal of Pediatric Orthopedics|February 4, 2025
An International Consensus on Evaluation and Management of Idiopathic Genu Valgum: A Modified Delphi SurveyAshish S Ranade, Gauri A Oka, Mohan V Belthur, et al.
Open Forum Infectious Diseases|September 4, 2023
The Penn Medicine COVID-19 Therapeutics Committee-Reflections on a Model for Rapid Evidence Review and Dynamic Practice Recommendations During a Public Health EmergencyGeorge L Anesi, Kathleen Degnan, Lauren Dutcher, et al.
Journal of Medicinal Chemistry|June 11, 2014
Tetrahydronaphthyridine and dihydronaphthyridinone ethers as positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu₅)Mark Turlington, Chrysa Malosh, Jon Jacobs, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 23, 2013
N-aryl piperazine metabotropic glutamate receptor 5 positive allosteric modulators possess efficacy in preclinical models of NMDA hypofunction and cognitive enhancementK J Gregory, E J Herman, A J Ramsey, et al.
Pageof 71

Showing results (681-690 of 709) with videos related to

Sort By:
Pageof 71
Nature Immunology|June 22, 2026
Fate induction through asymmetric T cell division is modulated by chimeric antigen receptor costimulatory domainsCaitlin S Frazee, Sisi Chen, Corbett T Berry, et al.
The American Journal of Sports Medicine|October 17, 2025
Risk Profile for Cyclops Syndrome Necessitating Reoperation After Anterior Cruciate Ligament ReconstructionTing Cong, Sahil Dadoo, Jumpei Inoue, et al.
Lung Cancer (Amsterdam, Netherlands)|May 19, 2024
Single organ metastatic sites in non-small cell lung cancer: Patient characteristics, treatment patterns and outcomes from a large retrospective Canadian cohortY Li, M Wong, L Zhan, et al.
Bioorganic & Medicinal Chemistry Letters|September 18, 2012
Optimization of an ether series of mGlu5 positive allosteric modulators: molecular determinants of MPEP-site interaction crossoverJason T Manka, Paige N Vinson, Karen J Gregory, et al.
Molecular Pharmacology|October 7, 2010
Discovery of novel allosteric modulators of metabotropic glutamate receptor subtype 5 reveals chemical and functional diversity and in vivo activity in rat behavioral models of anxiolytic and antipsychotic activityAlice L Rodriguez, Mark D Grier, Carrie K Jones, et al.
Frontiers in Plant Science|February 17, 2018
Latitudinal Patterns in European Seagrass Carbon Reserves: Influence of Seasonal Fluctuations versus Short-Term Stress and Disturbance EventsLaura M Soissons, Eeke P Haanstra, Marieke M van Katwijk, et al.
Journal of Pediatric Orthopedics|February 4, 2025
An International Consensus on Evaluation and Management of Idiopathic Genu Valgum: A Modified Delphi SurveyAshish S Ranade, Gauri A Oka, Mohan V Belthur, et al.
Open Forum Infectious Diseases|September 4, 2023
The Penn Medicine COVID-19 Therapeutics Committee-Reflections on a Model for Rapid Evidence Review and Dynamic Practice Recommendations During a Public Health EmergencyGeorge L Anesi, Kathleen Degnan, Lauren Dutcher, et al.
Journal of Medicinal Chemistry|June 11, 2014
Tetrahydronaphthyridine and dihydronaphthyridinone ethers as positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu₅)Mark Turlington, Chrysa Malosh, Jon Jacobs, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 23, 2013
N-aryl piperazine metabotropic glutamate receptor 5 positive allosteric modulators possess efficacy in preclinical models of NMDA hypofunction and cognitive enhancementK J Gregory, E J Herman, A J Ramsey, et al.
Pageof 71